Metabolic syndrome and antipsychotic therapy: A summary of the findings
Document Type
Conference Proceeding
Date of Original Version
4-1-2003
Abstract
Therapy with antipsychotic agents can lead to weight gain and elevation in serum triglyceride levels and has been associated with glucose dysregulation. Baseline screening plus monitoring of weight and blood glucose and lipid levels in patients receiving antipsychotics are essential to avoid metabolic problems while maintaining optimum therapy for mental illness.
Publication Title, e.g., Journal
Drug Benefit Trends
Volume
15
Issue
SUPPL. B
Citation/Publisher Attribution
Dufresne, Robert L.. "Metabolic syndrome and antipsychotic therapy: A summary of the findings." Drug Benefit Trends 15, SUPPL. B (2003): 12-17. doi: 10.1097/MED.0b013e32833de61c.
COinS